Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ C13orf15 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA566622

Catalog No. PIPA566622


Only null left
Add to Cart

Description

Description

Immunogen sequence: LSDALCEFDAV LADFASPFHE RHFHYEEHLE RMK Highest antigen sequence identity to the following orthologs - mouse 94%, rat 94%.

Modulates the activity of cell cycle-specific kinases. Enhances CDK1 activity. May contribute to the regulation of the cell cycle. May inhibit growth of glioma cells by promoting arrest of mitotic progression at the G2/M transition. Fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

C13orf15
Polyclonal
Unconjugated
RGCC
1190002H23Rik; bA157L14.2; C13orf15; regulator of cell cycle; regulator of cell cycle RGCC; Response gene to complement 32 protein; Rgc32; RGC-32; Rgcc
Rabbit
Antigen Affinity Chromatography
RUO
28984
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Immunocytochemistry
0.2 mg/mL
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
Q9H4X1
RGCC
Recombinant Human C13orf15. Recombinant protein control fragment (Product #RP-107280).
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.